Nephrology Department, Hospital Ramón y Cajal, Carretera de Colmenar km 9, Madrid, Spain.
Nefrologia. 2011;31(6):677-82. doi: 10.3265/Nefrologia.pre2011.Sep.11014.
The aim of this work was to study the accuracy of the CKD-EPI equation to estimate the glomerular filtrate in patients with advanced chronic renal failure.
We compared the estimations of Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and Cockcroft-Gault (CG) equations to a glomerular filtration rate measured as the arithmetic mean of the urea and creatinine clearances (ClUrCr).
The study was made in 89 nondialyzed patients with chronic renal disease in stage 4 or 5. Serum creatinine values were recalibrated to standardized creatinine measurements. In each patient, the difference between each estimating equation and the measured glomerular filtration rate was calculated. The absolute difference expressed as a percentage of the measured glomerular filtration rate indicates the intermethod variability.
Overall, the glomerular filtration rate measured as the ClUrCr was 14.5 ± 5.5 ml/min/1.73 m(2); and the results of the estimating equations were: MDRD 14.3 ± 5.5 (p = NS); CKD-EPI 13.6 ± 5.4 (p <0.01) and CG 16.8 ± 6.5 ml/min/1.73 m(2) (p <0.001). The variability of the estimating equations was 16 ± 12.2%, 16.7 ± 12,1% and 22 ± 15.6% (p <0.05), for MDRD, CKD-EPI and CG. The percentage of estimates within 30% above or below the measured glomerular filtration rate was 85% for MDRD, 88% for CKD-EPI and 70% for CG. The CG variability, but not MDRD variability or CKD-EPI variability, was influenced by gender (19.3 ± 15.1% in males vs 27.3 ± 15.5% in females, p <0.05) and showed a negative correlation with the glomerular filtration rate (r = -0.23, p <0.05) and the age (r = -0.24, p <0.05) and positive correlation with the body mass index (r = 0.37, p <0.001). In patients with chronic renal disease in stage 5, the variability of the different estimating equations was similar.
We conclude that in our population with advanced chronic renal failure, the CKD-EPI equation is as accuracy as the MDRD equation. With standardized creatinine the CG equation has a lower accuracy and its utilization may be reconsiderated.
本研究旨在探讨 CKD-EPI 方程在评估晚期慢性肾衰竭患者肾小球滤过率时的准确性。
我们比较了改良肾脏病膳食研究(MDRD)、慢性肾脏病流行病学合作(CKD-EPI)和 Cockcroft-Gault(CG)方程对以尿素和肌酐清除率算术平均值(ClUrCr)测量的肾小球滤过率的估计值。
本研究纳入了 89 例非透析慢性肾脏病 4 或 5 期患者。血清肌酐值经标准化肌酐测量值重新校准。在每位患者中,计算每个估算方程与实测肾小球滤过率之间的差异。以实测肾小球滤过率的百分比表示的绝对差值表明了方法间的差异。
总体而言,ClUrCr 测量的肾小球滤过率为 14.5 ± 5.5 ml/min/1.73 m²;估算方程的结果为:MDRD 为 14.3 ± 5.5(p = NS);CKD-EPI 为 13.6 ± 5.4(p <0.01)和 CG 为 16.8 ± 6.5 ml/min/1.73 m²(p <0.001)。估算方程的变异性为 16 ± 12.2%、16.7 ± 12.1%和 22 ± 15.6%(p <0.05),分别用于 MDRD、CKD-EPI 和 CG。估计值在实测肾小球滤过率上下 30%以内的比例为 85%用于 MDRD,88%用于 CKD-EPI 和 70%用于 CG。CG 的变异性(但不是 MDRD 或 CKD-EPI 的变异性)受性别影响(男性为 19.3 ± 15.1%,女性为 27.3 ± 15.5%,p <0.05),并与肾小球滤过率(r = -0.23,p <0.05)和年龄(r = -0.24,p <0.05)呈负相关,与体重指数(r = 0.37,p <0.001)呈正相关。在慢性肾脏病 5 期患者中,不同估算方程的变异性相似。
我们的结论是,在我们晚期慢性肾衰竭患者的人群中,CKD-EPI 方程与 MDRD 方程一样准确。使用标准化肌酐后,CG 方程的准确性较低,其应用可能需要重新考虑。